By encapsulating all these three drugs in a highly biocompatible nanocarrier i.e. HSA-NPs with proper physiochemical properties, the limitations associated with administration of the free drugs like poor water solubility, non-specificity, systemic toxicity, low plasma half-life, and MDR effect can be overcome and a tremendous effect of cancer theranostics can be achieved [5,11,15]. Here, ALB is linked to cancer.